SunGlow Innovations LLC
U.S. sponsor for the planned CDX-101 clinical research program and participant in veterinary drug development.
SunGlow Innovations
Drug development and research collaboration in the United States and China.
U.S. sponsor for the planned CDX-101 clinical research program and participant in veterinary drug development.
北京万斌赛尔生物技术有限公司
China applicant for the investigational drug program and coordinator of domestic clinical research preparation.
The program studies image-guided intratumoral delivery and local reaction assessment. Published patent application US20190015445A1 is an example of related research on chlorine dioxide injections.
Collaboration areas include hospital-based clinical research, veterinary oncology, international development and business or investment partnerships.